跳至主要内容
临床试验/NCT02535546
NCT02535546已完成不适用

Characterisation of Isolates of Streptococcus Pneumoniae in Patients With Chronic Obstructive Pulmonary Disease

Beaumont Hospital1 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2014年7月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
150
试验地点
1
主要终点
Carriage rate of Streptococcus pneumoniae in patients with COPD over four seasons.

研究概览

简要总结

Patients suffering from chronic obstructive pulmonary disease (COPD) commonly get exacerbations of their illness which have many potential triggers including infection. The most common cause of lung infection/pneumonia is an organism named Streptococcus pneumoniae. In Ireland a 13-valent pneumococcal conjugated vaccine (PCV-13) was recently introduced into the childhood vaccination programme. This study aims to investigate the carriage rate of S. pneumoniae in COPD patients over one year and to determine if isolates of S. pneumoniae found within the COPD population would be covered by the PCV-13 vaccine.

详细描述

This study aims to determine the potential contribution of S. pneumoniae to the morbidity of patients with COPD in Ireland and if the PCV-13 has potential for reducing infective exacerbations in this cohort. A group of 150 COPD patients are being monitored at quarterly intervals over one year. At each study visit patients report changes to COPD-related medication, recent hospitalisations and exacerbations and provide a sputum sample (or pharyngeal swab if not possible) which is assessed for the presence of S. pneumoniae.

The specific objectives of the study are:

  1. To monitor the carriage rate of pneumococci in a cohort of Irish patients with COPD during and outside periods of acute exacerbation over a one year period.
  2. To assess the COPD exacerbation rate amongst this group of patients.
  3. To monitor changes in the proportion of patients positive for pneumococci carriage over a full season and to document those patients intermittently or permanently colonised.
  4. To characterise S. pneumoniae isolates carried by COPD patients in terms of their genetic evolution, comparison with strains in other countries, and antimicrobial susceptibility.
  5. To assess the proportion of colonised COPD patients that would be covered by current and future pneumococcal vaccines.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Over 18 years of age.
  • •Have a clinical diagnosis of COPD.
  • •Have a forced expiratory volume at one second/forced vital capacity (FEV1/FVC) ratio < 80%.

排除标准

  • •Patients too unwell.

结局指标

主要结局

Carriage rate of Streptococcus pneumoniae in patients with COPD over four seasons.

时间窗: One year.

Patients with COPD are being monitored over a one year period for carriage of S. pneumoniae. Carriage is determined by analysis of sputum or pharyngeal swab samples which are collected from patients at quarterly intervals.

次要结局

  • Characterisation of carriage isolates of Streptococcus pneumoniae from COPD patients.(One year.)

研究者

发起方
Beaumont Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Professor Richard Costello

Professor Richard Costello

Beaumont Hospital

研究点 (1)

Loading locations...

相似试验